It has been very promising in its treatment. The human body produces its own cannabinoids, called endocannabinoids, aided by the consumption of fatty acids found in foods such as fish, nuts and seeds. The studies affected that CBD is able to interact with the body’s endocannabinoid system. The endocannabinoid system is a network of mobile receptors and molecules that help regulate human functions such as mood, appetite and sleep. By binding to specific receptors in the human brain, endocannabinoids increase the action of serotonin, a neurochemical that improves mood and relieves stress.



How does CBD combat the symptoms of seasonal affective disorder?

The winter months bring short days and less sunlight, factors that can contribute to seasonal affective disorder, also known as SAD. We now know that CBD could fight your symptoms, such as anxiety and sleep problems.

Winter brings shorter days, less exposure to sunlight and colder weather. Some people love winter and love the nostalgia of snuggling between blankets while they drink hot drinks. However, these environmental changes can profoundly and negatively affect some people, leading to a decrease in mood, feelings of sadness and depression. This phenomenon is known as seasonal affective disorder (SAD) and is considered a major depressive disorder. The APR can be treated through several lifestyle factors, such as a healthy diet, physical exercise and a good sleep cycle. Some patients take antidepressant medications. The compounds present in cannabis plants are also being investigated for their possible effect on the symptoms associated with SAD.


For now, the causes of SAD are unknown, but it is believed that it is partly due to the decrease in exposure to sunlight. Sunlight is essential for the health of the human being, on which it exerts numerous positive effects, from favoring the assimilation of vitamin D to marking the circadian rhythm or sleep-wake cycle. It is believed that the lack of sunlight prevents a part of the brain, known as the hypothalamus, from functioning properly. The hypothalamus is a gland that plays a crucial role in the endocrine and nervous systems, and is involved in the regulation of body temperature and the release of hormones.

Hypothalamus dysfunction could affect the production of melatonin, a hormone released by the pineal gland to numb the body. Blue light inhibits the production of melatonin, and lack of light leads to an increase in the production of this hormone. Therefore, people with SAD have a high level of melatonin during the darkest months of the year, which translates into a frequent feeling of tiredness. This alteration of the function of the hypothalamus could also affect the production of serotonin, a neurotransmitter that has a very important role in the regulation of mood, appetite and sleep. The decrease in sunlight can lead to a very poor synthesis of serotonin, which contributes to moodiness and depression.


Anxiety is perhaps one of the most prevalent mental disorders in modern societies. In this context, research on the anxiolytic properties of cannabidiol or CBD acquires great importance.

The review of the legality of cannabis and its components in certain parts of the world is a more than anecdotal phenomenon: it is a trend that is also stimulating scientific research in a field as promising as cannabinoids.








In a 500-page report by the National Academy of Sciences, Engineering and Medicine on the health effects of cannabis and cannabinoids, it was determined that there is “strong evidence from randomized controlled trials to support the conclusion that cannabis or cannabinoids are an effective treatment “against chronic pain, nausea and vomiting, spasticity associated with multiple sclerosis and other conditions.

On the potential of cannabis to treat anxiety, although the evidence is limited according to the report, it is enough to suggest the convenience of continuing to investigate in that direction.

The report cites one of the most reliable studies on the medicinal use of cannabis, consisting of a systematic review and meta-analysis of 79 trials, one of which investigated the ability of the CBD to reduce anxiety, finding that the CBD was more effective than the placebo.


Neurotherapeutics published in 2015 a report “to determine the potential of CBD against anxiety, that is, as a treatment for anxiety-related disorders”, finding that “CBD has considerable potential as a treatment for multiple anxiety disorders given its anxiolytic, panicolitic and anticompulsive properties, as well as a decrease in the conditioned expression of fear, the increase in the extinction of fear, the blockage of reconsolidation and the prevention of the long-term anxiolytic effects of stress ”.

Although the report suggests “the need for additional studies of chronic and therapeutic effects in the relevant clinical populations,” it seems that CBD could not be profiled against anxiety, but also as a remedy to reduce the severity of seizure attacks. Panic, fear and stres.


CBD can be outlined as a complementary treatment to help reduce the consumption of other medications whose side effects can range from annoying to devastating. In 2016, a study evaluating the response of a 10-year-old girl with post-traumatic stress to a treatment with CBD oil found promising results. Before the age of 5, the girl had suffered sexual abuse and abuse, and began receiving drug treatment that, in the best case, produced short-term relief, but the side effects began to be intolerable.

However, under treatment with CBD oil, the girl began to experience “a sustained decrease in anxiety and a constant improvement in the quality and quantity of sleep.”


However, this type of case reveals one of the many limitations that cannabinoid medical research still suffers, more a consequence of the legal status of cannabis than the competence of researchers. Most studies rely on personal or anecdotal reports, or very small population samples. In addition, there are practically no studies that determine the relationship between dose and effects.

While the necessary research continues to develop, we already know some of the mechanisms of interaction of CBD with our endocannabinoid system that allow us to establish its ability to reduce anxiety.



On one hand, CBD delays serotonin signaling, which boosts its antidepressant, anxiolytic, anti-addictive and antiemetic properties, as well as facilitating sleep. On the other hand, CBD is an allosteric modulator, which allows you to change the shape of GABA-A (Gamma-Aminobutyric), an inhibitory neurotransmitter, so that it improves the sedative effects of the receptor.

In conclusion, although science is still inconclusive, the accumulated evidence points in a clear direction: CBD has the ability to reduce anxiety. Of course, what we are trying to do now is to improve the quality of research with large long-term population studies, determining doses and routes of administration, to know the extent of CBD’s properties against anxiety.


Unlike cannabis, many pharmaceutical treatments result in physical addiction, including withdrawal or when abruptly interrupted. In addition, most of these medications can lead to an overdose, something that is impossible with marijuana (even with concentrates such as kief, hash oil and wax).

In 2014, a school teacher in California reported that she collapsed on the floor of her kitchen and was unconscious for more than an hour. Upon waking, he suffered tremors and hallucinations. “I felt these horrible shocks running through my head and my body; I couldn’t stop moving. Then I started to see things that weren’t there, creepy things. I didn’t know what was happening, but I worried that I was dying.

Unfortunately, these were simply the withdrawal symptoms of Xanax, a drug he used for more than eight years to combat insomnia, which his doctor believed was caused by anxiety.


In 1982, a study published in the journal Psychopharmacology revealed that CBD, the non-psychoactive cannabinoid that is commonly used to treat childhood epilepsy and put cancer in remission, decreased the anxiety experienced by large amounts of THC.

According to a 1999 study published in The Journal of Clinical Psychiatry, anxiety disorders cost the United States more than $ 40 billion, about a third of the nation’s $ 150 billion bills at the time.

In 2011, researchers from the University of Sao Paulo in Brazil gave doses of 400 mg of CBD to patients suffering from generalized social anxiety disorder (SAD), a condition that affects approximately 12 percent of Americans at some time of their lives. It was found that cerebral blood flow after CBD treatment indicates an anxiolytic (anti-anxiety) effect in the regions of the brain that control emotions.

He studies concluded: “In relation to placebo, CBD was associated with a significant decrease in subjective anxiety …. These results suggest that CBD reduces anxiety in SAD [Social Anxiety Disorder].” A study published in 2012 concluded that cannabis helps patients erase bad memories. The study observed: “For both anxiety and fear memory processing, endocannabinoid signaling can guarantee an adequate reaction to stressful events. Therefore, the ECS [endocannabinoid system] can be considered as a regulatory system for buffer damping. emotional responses. ”

Original source: http://nekwo.com/cbd-contra-la-ansiedad/


Every day there is more research in which it is shown that cannabis can be both an adjunct to existing conventional drugs to treat pain, as an alternative, natural, organic or ecological, effective and cheaper medicine for these drugs.

Pain is a universal disorder that is one of the biggest challenges for public health, both in clinical and economic terms and that not only affects the person who suffers it, but has an immense impact on their environment. There is nothing more desperate for a patient and his relatives than the first’s suffering of chronic pain, which when not treated properly can affect the dignity of the person. Numerous medical pathologies present with pain: arthritis, migraines, neuronal lesions, cancer and much more. Numerous drugs for the treatment of pain are currently available with a varying degree of efficacy, according to each patient and each pathology. Every day there is more research in which it is shown that cannabis can be both an adjunct to existing conventional drugs to treat pain, as a substitute medicine for these drugs. In fact, among all patients who use medicinal cannabis, one of the main pathologies for which they use it is to treat chronic pain.

Patients registered in the medical cannabis programs of the United States, 92.2% of patients use it for the treatment of severe and chronic pain (173). A sample of 628 medical cannabis users in Canada, pain was among the three main symptoms. 72% of the patients reported that cannabis was always useful and 24% that it was frequently. Although slightly more than half of the total sample said to use other medications; Of these, almost 80% said that cannabis had fewer side effects than other drugs (174). Having this reference, it can be understood that even in this sense the acceptance of medical cannabis can be favorable for the scientific world, providing important value to patients and their obstacles to good health.

Clinical trials in chronic pain relief

In relation to an international sample that included patients from different European and North American countries, the main medical condition for which patients used medical marijuana was also chronic pain (29.2%) (175). In a survey conducted in the United Kingdom among patients who self-medicated with cannabis, 40% reported doing so for the treatment of pain and, in Spain, a survey conducted on 2250 patients on the use of medical cannabis to treat their medical conditions, Of which 5.8% responded, 44.6% said they used it to treat pain symptoms (176). Regarding the relief of symptoms, in a North American survey composed of 97% of patients with chronic pain, the degree of relief they experienced when using cannabis was asked: on a scale of 0 to 10 pain intensity, the decrease The average was 5 points (7.8 to 2.8) between before and after using cannabis, which implies an average relative decrease of 64%. Half of the respondents also reported experiencing relief from stress and anxiety secondary to the disease and almost half (45%) reported relief from insomnia. The majority of patients (71%) did not report experiencing adverse effects (177). These analyzes and also in other statistics we see the increase in use and positive applications, it is a fact that in many countries the legalization for its medical use is already being implemented and it will grow in high demand.


Receptors, endogenous cannabinoid system and effects

The endocannabinoid system works retrograde, that is, inhibiting the activation of signals in response to excessive neuronal activity. This inhibition of neuronal firing manifests itself in the pain pathways in the form of analgesia and reduced pain sensitivity. There is a great abundance of CB1 receptors both in the brain areas responsible for processing pain, and in the peripheral nerves that transmit painful sensations to the brain, as well as in the brain areas related to the effective assessment of pain (fronto-limbic areas). On the other hand, CB2 receptors play an important role in reducing inflammatory processes and, above all, in signaling pain and can be of particular relevance in chronic pain states. In addition, both anandamide and 2-AG have been shown to have analgesic properties in numerous animal model studies (178). The knowledge of the involvement of the endogenous cannabinoid system, together with the accumulation of evidence from animal research, indicates that pharmacological modulation by means of cannabinoids is an extremely interesting strategy for the treatment of refractory and chronic pain states.



So far, clinical trials have been carried out both with marijuana and with different natural and synthetic cannabinoids in which more than 1000 patients have participated, showing efficacy in different types of chronic pain, the majority of studies with patients with neuropathic pain ( 179) (a type of pain resulting from a lesion in the central and / or peripheral nervous system) that occurs in diseases of the nervous system such as multiple sclerosis, but also in other types of diseases such as diabetes. Both THC and its synthetic analogs (nabilone and dronabinol) and Sativex have been found useful in clinical trials conducted so far. For its part, the CBD, in addition to also possessing analgesic properties (180), its ability to reduce the adverse psychological effects of THC, as well as its potential as an anxiolytic, makes its combination with THC, or its presence in herbal cannabis, help with THC to facilitate its analgesic property.


Not only THC and CBD, the main phytocannabinoids of the cannabis plant, have analgesic properties. Other non-psychoactive phytocannabinoids such as tetrahydrocannabivarin (THCV), cannabigerol (CBG) and cannabichrome (CBG) are also throwing evidence. And what is more interesting: it seems that the terpenes present in the cannabis plant also interact with the phytocannabinoids to synergistically enhance the analgesic effect with them (181). Terpenes are molecules that provide smell and aroma to many food products and are designated by different regulatory agencies, including the FDA (Food and Drug Administration), as “generally recognized as safe.” This phenomenon makes the use of the cannabis plant, with its rich composition in different cannabinoids and terpenes, considered a more interesting strategy than the administration of isolated compounds (182), and that there is even evidence of studies in animal models that They point in that direction (183).


Finally, there are more and more clinical studies (184), research based on surveys (185) and anecdotal cases (186), which show how in patients with chronic pain in treatment with opiates, the use of marijuana allows them to reduce the amounts of opioids they drink. Something, on the other hand, that is in line with animal and pharmacological research, in which there are abundant studies in which it has been found that the combination of cannabinoids with opiates acts synergistically (187) so that lower doses are needed of opiates to achieve the analgesic effect, which considerably reduces the risk of overdose, which, unlike cannabis, in the case of opiates can be fatal. In fact, a recently published study has found that in the US states where the use of medical marijuana is legalized, the number of overdose deaths caused by analgesic drugs, mainly opiates, is 24.8% lower than in the other states (188).



Reference and support

173. Bowles DW. (2012). Persons registered for medical marijuana in the United States. J Palliat Med. 15(1):9-11.

174. Walsh Z, Callaway R, Belle-Isle L, Capler R, Kay R, Lucas P, Holtzman S. (2013). Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use. Int J Drug Policy. 24(6):511-6

175. Hazekamp A, Ware MA, Muller-Vahl KR, Abrams D, Grotenhermen F. (2013). The medicinal use of cannabis and cannabinoids–an international cross-sectional survey on administration forms. J Psychoactive Drugs. 45(3):199-210.

176. Borras R, Modamio P, Lastra CF, Marino EL. (2011). Medicinal Use of Cannabis in Spain. Altern Ther Health Med. 17(5):52- 54.

177. Webb CW, Webb SM. (2014). Therapeutic benefits of cannabis: a patient survey. Hawaii J Med Public Health. 73(4):109- 11.

178. Woodhams SG, Sagar DR, Burston JJ, Chapman V. (2015). The role of the endocannabinoid system in pain. Handb Exp Pharmacol. 227:119-43.

179. Fine PG, Rosenfeld MJ (2013). The endocannabinoid system, cannabinoids, and pain. Rambam Maimónides Med J. 4(4):e0022.

180. Maione S, Piscitelli F, Gatta L, Vita D, De Petrocellis L, Palazzo E, de Novellis V, Di Marzo V. (2011). Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action. Br J Pharmacol. 162(3):584-96

181. See foot 7 y 8.

182. Gertsch J, Pertwee RG, Di Marzo V. (2010). Phytocannabinoids beyond the Cannabis plant – do they exist? Br J Pharmacol. 160(3):523-9.

183. Comelli F, Giagnoni G, Bettoni I, Colleoni M, Costa B. (2008). Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved. Phytother Res. 22(8):1017-24.

184. Abrams DI, Couey P, Shade SB, Kelly ME, Benowitz NL. (2001). Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther. 90(6):844-51.

185. Degenhardt L, Lintzeris N, Campbell G, Bruno R, Cohen M, Farrell M, Hall WD. (2015). Experience of adjunctive cannabis use for chronic noncancer pain: findings from the Pain and Opioids IN Treatment (POINT) study. Drug Alcohol Depend. 147:144-50.

186. Krawitz M. (2015). Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates. AMA J Ethics. 17(6):558-61.

187. Cichewicz DL. (2994). Synergistic interactions between cannabinoid and opioid analgesics. Life Sci. 74:1317–1324.

188. Bachhuber MA, Saloner B, Cunningham CO, Barry CL. (2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 174(10):1668-73.


CBD and children health hope

In recent years, the medical use of medical cannabis has begun to expand throughout the world due to the benefits it reports for the treatment of some pathologies. In this regard, a study conducted at the Hebrew University of Jerusalem found that one of its components prevents early neuronal death and extends the life of brain cells, thus preventing degenerative diseases such as epilepsy.


Children in hospital

CBD and its benefits

Other research published in the American Journal of Medicine revealed that its medicinal consumption can reduce blood glucose levels and prevent the onset of obesity and diabetes.

It has also been shown that some components of medicinal cannabis have analgesic and anti-inflammatory properties that are very effective in treating pain and various autoimmune diseases. In fact, some studies have revealed that it could also be very effective in fighting tumors.

Although the Food and Drug Administration of the United States has not recognized it as a medicine since to do so it would need to have several rigorous and generalized clinical trials, which so far have not been performed, the truth is that several scientific studies have demonstrated its effectiveness in the treatment of some pathologies. In fact, in several states of USA its medicinal consumption has been legalized and it has even begun to be used in children to relieve multiple ailments.

Medical Cannabis

CBD oil and epilepsy in children

A study published recently in the Proceedings of the National Academy of Sciences found that regular consumption of cannabidiol for medical purposes can reduce the frequency and intensity of seizures in children with severe epilepsy who do not respond to other treatments. To arrive at these results, the researchers administered 137 patients cannabidiol orally for 3 months, in that period 6%, that is 12 participants, had to leave the treatment due to the side effects of the drug. However, in the rest of the patients, the seizures were reduced by approximately 54%.


Can all children benefit from cannabis treatment?

The American Pediatric Association recommends that medical cannabis treatment be limited exclusively to children who have limiting or life-threatening diseases, for which there is no other successful therapy. In the United States, many children have begun to benefit from its effects, but in Spain, the prescription of Cannabis treatment is still subject to strict control since it is only used to treat multiple sclerosis.
Hence, at least 300 families are “illegally” medicating their children with cannabidiol to relieve their various symptoms.

Seizures are much more dangerous than cannabis

if we have a child who is convulsing 300 times a day, who with each seizure loses an incredible amount of neurons, which has neurological damage, logically that the potential risk that perhaps in the future this early use may eventually generate five points less than CI is an argument that is not valid.


How Does CBD Affect Minors Suffering from Epilepsy?

Since 2008, the number of publications related to the extraction of cannabinoids, CBD oil, has increased considerably, with today more than 1205 publications in scientific bases such as PubMed. Among the research with human patients, examples such as Porter and Jacobson are worth mentioning. In this study, the evolution over time after doses of CBD oil is documented in a group of 19 children (ages 2 to 16), resistant to conventional antiepileptic treatments, it is also documented that these individuals were treated with about 12 different types of drugs, prior to the start of the study.

It was found that more than 50% of the individuals presented drastic reductions in the number of seizures after the dose of CBD oil and without the presence of typical adverse effects mentioned above. Even more interesting, the dosage provided was a daily dose of 0.5mg / kg up to 28.6 mg / kg.

During progressive follow-up, parents and family members report that patients were released from seizures after 4 months of uninterrupted daily use. Other cases mention up to 80% reduction in the frequency of attacks.

It should be noted that these improvements also influenced other aspects of patients’ daily lives such as: improved mood, better sleep and increased alertness.

Parallel studies in healthy patients, report having implemented doses as high as 600mg in the use of CBD oil, this dosage showed to be very well tolerated and without producing psychotic symptoms in individuals.


Happy childre cbd


The cannabis plant is made up of two main players: CBD and THC. “CBD is the non-psychoactive portion of the plant, so what that means is you won’t have any effects like euphoria,” says Junella Chin, DO, an osteopathic physician and medical cannabis experts. “You won’t feel sedated or altered in any way.”

Regarding this very important point, medical cannabis can be used for many different treatments, inclusive children can be relived from seizures.

In spite of the obstacles, the increasing investigations in this respect and the success stories reported by parents and users make the regulations change.

No parent wants to see their children suffer, and if cannabis can help children with chronic illnesses or cancer patients have a better quality of life, parental pressure will continue on legal bodies. Science is on your side.

Runing childre cbd

“The study was sponsored by the Alaska Mental Health Authority, the Arizona Department of Health Services, the California Department of Public Health, the Centers for Disease Control and Prevention (CDC), the CDC Foundation, the FDA, Mat-Su Health Foundation, Traffic Safety Administration, National Institutes of Health: National Cancer Institute and National Institutes of Health National Institute of Drug Abuse; the Oregon Health Authority, the Robert W. Woodruff Foundation, the Colorado Health Foundation, the Truth Initiative and the Washington State Department of Health. The National Academies of Science, Engineering and Medicine are private nonprofit institutions that provide independent and objective analysis and advice to the nation to solve complex problems and inform public policy decisions related to science, technology and medicine. The National Academies operate under a constitutional letter of 1863 to the National Academy of Sciences, signed by President Lincoln.”



Wellcome to a new and important article, but please let me tell you a bit about my self

I am a first son, father, husband, with a medical degree based in Phycho-bio-social- preparation profile, where we look into the patient and make a general study of how and where the patient lives, study and work.


I am not trying to medicate anybody but share the knowledge I have gathered by curing my self for a better and longer life, as I see the CBD products are changing lives worldwide.

​I’m not taking any claim to diagnose or cure any disease with CBD oil, is really important to take and understand this point.

​And there is something to look at when we define it is:

Psoriasis and a ….

Psoriasis is a common, chronic, genetic, systemic inflammatory disease that is characterized by symptoms and signs such as elevated itchy plaques of raised red skin covered with thick silvery scales. Psoriasis is usually found on the elbows, knees, and scalp but can often affect the legs, trunk, and nails.

​This is a very exciting subject it is a big topic

​I want to talk about the benefits of CBD OIL for psoriasis and eczema in this article.

​Eczema used to be treated differently because we thought it was an allergy but now after around 5-6 years ago the science found out it is also an autoimmune condition.

The difference:

Psoriasis autoimmune condition causes the proliferation of skin cells, they stack on top of each other, not only does stack and creates scales a lot of inflammation and a real problem.

Eczema is more just inflammation and the itchy but.

When you heard about skin in conventional medicine what will do to resolve this is only a topical solution, and there is the problem, Eczema and Psoriasis is not really a skin problem, that it’s an inside problem expressing itself at the skin level. Literally an internal problem expressing itself on the surface of the skin.

The bigger problem becomes when the conventional pharmaceutics solution are telling you to use medication than suppress your immune system, because that is what is happening to cure your skin problem, does that sound right to you? I was told at school than my immune system is very important regarding my good health, so why I want to suppress that?

How CBD oil helps people?

There is a full treatment possible to accomplish with the CBD oil, how can we do this?

Topically: (CBD cream) Put it on your skin directly on your wounds for eczema and psoriasis, the antiinflammatory properties of CBD will help to calm it down, you can put on directly the CBD oil drop mix with a hemp organic oil on the affected areas also.

Internally: Put in directly CBD oil drops underneath your tongue, it will help to balance you internal inflammatory activity’s in your guts, and that is one of the many golden solutions than CBD does to you, calm, balance, anti-inflammatory job from the deep inside if where all the good bacteria and the immune system response directly when homeostasis is affected.

After looking at 2 different ways to make a more effective treatment, it takes 2 actions to have and achieve good results.

80% of the immune system lives in our gut’s, but also almost all autoimmune conditions have their origins somewhere from the guts as well, so when there is inflammation in the gut, the immune system triggers the fire in the whole immune system, and now the immune system is hyperactive and starts attacking skin cells and that’s how it flares psoriasis and eczema. So CBD oil calms down gut inflammation, and so the chain reaction of the system, which will stop the symptom of itchy, scratchy and relieving you from pain and psychologic misery.

CBD oil makes the gut to become stronger and may help reduce the leaky gut, all that has to be inside the gut will keep remaining inside and will not go in to the blood system and you immune system will be more relax and calm, and if there is already a leaky gut will heal the gut from leaking.

CBD oil has a very positive impact on the microbiota environment.

It is another alternative way of gets natural solutions for this health problem,

As is known and accepted very well today, one of the main functions of CBD is to attach to endogenous cannabinoid receptors in our organisms. After this union, a metabolic cascade of effects is produced, among which there is an anti-inflammatory tissue activity. Thanks to the fact that CBD is a molecule easily absorbed through the skin, and even more so through sublingual application (CBD oils), this molecule has proven to be a potential ally against the typical symptoms of this disease. Among other advantages of using CBD oil is that it does not present any type of toxicity or signs of overdose. Finally, this cannabinoid has antioxidant properties and some protection against UV rays, making the range of benefits of CBD ideal for patients with skin conditions.


Within the cannabinoid research groups, there is a group led by Dr. Mechoulam in Israel, whose government has implemented a National Plan for Medicinal Cannabis a couple of months ago. This ambitious initiative has led not only researchers and doctors, but also the general public, to take a greater interest in these compounds and the great inherent therapeutic potential.

As it is present today, the potential of CBD oil can help in skin conditions such as psoriasis and the reduction of scales/rushes/itching /irritation.

The best products are from organic cultivations, the best way to support the CDB movement is to respect the fact of not THC.


art. The economist

“The doctor was blunt with Hannah Deacon, the mother of an epileptic boy. He told her that she would “never” get a prescription on the National Health Service (nhs) for medicine based on tetrahydrocannabinol (thc), the psychoactive ingredient in cannabis. The British government, too, was unhelpful, maintaining in February 2018 that cannabis had no medical value—a position that it had held for over 50 years, even as the country grew and exported cannabis for medicinal use. Yet within months, it had made a u-turn, accepting that Cannabis sativa had medical uses. Eight months after Ms Deacon made her first public plea for it, her son, Alfie, got thc-based medicine on the nhs.

Legislatures across the planet have been having similar changes of heart. This may presage broader legalisation. History suggests that when medical cannabis is permitted this is often the prelude to broader recreational access.”

(NHS)The National Health Service of the United Kingdom

The secret to the success of this therapy must be from the inside out.